Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

Bullboard Posts

Post by goldboy1on Oct 02, 2007 3:45pm

177 Views

Post# 13509162

3

to IR and they are expecting drill results bye the end of this week from the Cold Lake Deposit as well as a new anomaly they have been drilling. There is only 40million issued on this thing, 6 deposits so far, 2.5million in the bank, 50,000 meter drill program under way, 2 more drills coming next week. This means a lot more news on the way.

Bullboard Posts

Morning Market Outlook for Nov. 7, 2024